Examples of using Eylea in English and their translations into Italian
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
The European Medicines Agency has waived the obligation to submit the results of studies with Eylea in all subsets of the paediatric population in wet AMD,
The safety and efficacy of Eylea when administered to both eyes at the same time has not been studied and if used in this way may lead to an increased risk of experiencing side effects. injections with Eylea may cause an increase in eye pressure(intraocular pressure) in some patients
Eylea should not be used in pregnancy unless the potential benefit outweighs the potential risk to the unborn child. women of childbearing potential have to use effective contraception during treatment and for at least three further months after the last injection of Eylea.
The safety and efficacy of Eylea were assessed in two randomised, multi-centre, double-masked, sham-controlled studies in patients with macular oedema secondary to CRVO(COPERNICUS and GALILEO) with a total of 358 patients treated and evaluable for efficacy 217 with Eylea.
Patients were randomly assigned in a 3:1 ratio to receive either 2 mg Eylea intravitreally or sham injections administered once at study start with additional injections given monthly
after the first initial year of Eylea treatment, the standard regime of injections every 8 weeks with alternative treatment regimens,
After the first 12 months of treatment with Eylea, and based on visual and/or anatomic outcomes,
Eylea is indicated for adults for the treatment of neovascular(wet) age-related macular degeneration(AMD)(see section 5.1),
In patients treated with Eylea in the MYRROR study(one injection given at start of therapy, with additional injections given in case of disease persistence or recurrence), CRT decreased soon after treatment initiation favouring Eylea at week 24(-79 microns and -4 microns for the Eylea 2 mg treatment group
which is similar to the administered number of doses in the Eylea 2Q8 group in VIVIDDME and VISTADME, while overall efficacy of the aflibercept treatment group in Protocol T was comparable to the Eylea 2Q8 group in VIVIDDME and VISTADME.
agreement with the National Competent Authorities in each Member State where Eylea is marketed, at launch of the new indication myopic choroidal neovascularisation(myopic CNV) and periodically thereafter, all ophthalmological clinics where Eylea is expected to be used are provided with an updated physician information pack containing the following elements.
Eylea was shown to be as effective as ranibizumab in maintaining vision in patients with wet AMD: looking at the results of the two studies together, the proportions of patients who maintained vision were 96.1%(517 out of 538), 95.4%(533 out of 559) and 95.3%(510 out of 535) for 0.5 mg Eylea every four weeks, 2 mg Eylea every four weeks and 2 mg Eylea every eight weeks, respectively, compared with 94.4%(508 out of 538)
What Eylea contains.
Stopping treatment with Eylea.
How does Eylea work?
Other information about Eylea.
Other medicines and Eylea.
How to store Eylea.
Why has Eylea been approved?
Who should be treated with Eylea.
